Latest News About - Veterinary Products

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Friday, January 18, 2019

6:44:00 PM CET

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Rusty Payne said: "We document the sales, what comes in and out, in terms of controlled substances, not all drugs, just controlled substances," External link

click2houston Friday, December 28, 2018 2:08:00 PM CET

Richard Pazdur said: “The approval of Ultomiris will change the way that patients with PNH are treated,” External link

fda Friday, December 21, 2018 4:56:00 PM CET

Richard Pazdur said: “Prior to today’s approval, there had been no FDA approved therapies for BPDCN. The standard of care has been intensive chemotherapy followed by bone marrow transplantation. Many patients with BPDCN are unable to tolerate this intensive therapy, so there is an urgent need for alternative treatment options,” External link

fda Friday, December 21, 2018 4:56:00 PM CET

Charles Long said: “The technology challenges of producing genetically engineered animals are gone,” External link

TorontoStar Tuesday, December 18, 2018 12:31:00 AM CET

Jennifer Kuzma said: “We’re at this inflection point in society, where gene editing is really taking off, and now is the time we could have a more sustained public conversation about how we want it used in our world and how we don’t want it to be used,” External link

TorontoStar Tuesday, December 18, 2018 12:31:00 AM CET

Charles Long said: “I’m angry as hell 90 per cent of the time,” External link

TorontoStar Tuesday, December 18, 2018 12:31:00 AM CET

Greg Jaffe said: “We need to rethink this — look at the science, look at the potential risk, look at the products that are going to be developed. Is there a need for oversight, and what is the appropriate mechanism for that oversight?” External link

TorontoStar Tuesday, December 18, 2018 12:31:00 AM CET

Jennifer Kuzma said: “It’s going to be a very closed process and a very cozy relationship between the technology developers and the federal government,” External link

TorontoStar Tuesday, December 18, 2018 12:31:00 AM CET

Jennifer Kuzma said: "We're at this inflection point in society, where gene editing is really taking off, and now is the time we could have a more sustained public conversation about how we want it used in our world and how we don't want it to be used," External link

thespec Monday, December 17, 2018 11:42:00 PM CET

Greg Jaffe said: "We need to rethink this - look at the science, look at the potential risk, look at the products that are going to be developed. Is there a need for oversight, and what is the appropriate mechanism for that oversight?" External link

thespec Monday, December 17, 2018 11:42:00 PM CET

Jennifer Kuzma said: "It's going to be a very closed process and a very cozy relationship between the technology developers and the federal government," External link

thespec Monday, December 17, 2018 11:42:00 PM CET

Most associated names

Daily number of articles in this category

Trend data not available for this selection.